According to Journey Medical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.94. At the end of 2024 the company had a P/S ratio of 1.55.
Year | P/S ratio | Change |
---|---|---|
2024 | 1.55 | 15.26% |
2023 | 1.35 | 191.79% |
2022 | 0.4614 | -67.5% |
2021 | 1.42 |